Physician profile
Karlee E Stermock
NPI 1679094973
$1,158.25
in general payments reported to CMS, 2019-2025
12 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $222 · 2023: $208 · 2024: $285 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $726.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $278.67 | 2021-2025 | |
| Organon LLC | $188.09 | 2021-2025 | Nexplanon |
| Abbvie INC. | $129.34 | 2023-2025 | |
| Exeltis, USA INC. | $122.38 | 2022-2024 | Slynd |
| Collegium Pharmaceutical, INC. | $104.52 | 2021-2024 | Xtampza |
| Viiv Healthcare Company | $94.55 | 2022-2023 | Apretude |
| Merck Sharp & Dohme LLC | $57.56 | 2021-2024 | Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $56.65 | 2023-2025 | |
| Biodelivery Sciences International, INC. | $49.76 | 2021 | |
| Agile Therapeutics, INC. | $30.90 | 2021 | |
| Medicines360 | $24.20 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.63 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karlee Stermock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.